Sandbox:Vindhya
Medical and Neurologic causes
Neurologic disorders | Cerebral neoplasms, cerebral trauma and post concussive syndromes ,Cerebrovascular disease, subarachnoid hemorrhage, Migraine, encephalitis,cerebral syphilis, Multiple sclerosis,Wilsons disease,Huntington disease,Epilepsy |
Endocrine disorder | Pituitary dysfunction, Thyroid dysfunction, parathyroid dysfunction, Adrenal dysfunction,pheochromocytoma |
Systemic conditions | Hypoxia, Cardiovascular disease, pulmonary insufficiency, anemia |
Inflammatory disorders | Lupus erythematosus, rheumatoid arthritis, polyarteritis nodosa, temporal arteritis |
Deficiency states | Vitamin B12 deficiency, pellagra |
Miscellaneous | hypoglycemia, carcinoid syndrome, uremia, premenstrual syndrome, porphyria |
Substances | Caffeine,cannabis,Hallucinogens, theophylline, amphetamines,yohimbine,sympathomimetics, mercury, Arsenic,organophosphates,benzene |
Withdrawal | alcohol,caffeine, opiods,antihypertensives |
siadh classification
Classification
- Acute setting (<48 hours since onset) where moderate symptoms are noted, treatment options for hyponatremia include the following:
- 3% hypertonic saline (513 mEq/L)
- Loop diuretics with saline
- Vasopressin-2 receptor antagonists (aquaretics, such as conivaptan or tolvaptan)
- Water restriction
- In chronic asymptomatic setting, the treatment is as follows:
- Fluid restriction
- Vasopressin-2 receptor antagonists
- Other agents to be considered include loop diuretics with increased salt intake, urea, and demeclocycline
- Raise serum sodium by 0.5-1 mEq/hr, and not more than 10-12 mEq in the first 24 hours,to avoid complications like Osmotic demyelination syndrome.
- In rare medical emergencies more commonly seen in cardiology in the context of hypervolemic severe hyponatremia rather than in SIADH :
- Continuous veno-venous hemofiltration (CVVH)
- Slow, low-efficiency daily dialysis (SLEDD have been used to improve hyponatremia. These methods are invasive so their use is very limited.[1]
- ↑ Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K (2009). "Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients". Clin J Am Soc Nephrol. 4 (8): 1338–46. doi:10.2215/CJN.02130309. PMC 2723965. PMID 19628685.